Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
CVS Quote, Financials, Valuation and Earnings
Last price:
$63.19
Seasonality move
:
-0.64%
Day range:
$63.73 - $64.71
52-week range:
$43.56 - $72.51
Dividend yield:
4.17%
P/E ratio:
15.23x
P/S ratio:
0.21x
P/B ratio:
1.05x
Volume:
5.8M
Avg. volume:
6.6M
1-year change:
6.23%
Market cap:
$80.7B
Revenue:
$372.8B
EPS (TTM):
$4.19
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $268.7B | $292.1B | $322.5B | $357.8B | $372.8B | |
| Revenue Growth (YoY) | 4.65% | 8.71% | 10.39% | 10.95% | 4.2% | |
| Cost of Revenues | $219.7B | $240B | $268B | $303.3B | $321.4B | |
| Gross Profit | $49B | $52.1B | $54.5B | $54.4B | $51.4B | |
| Gross Profit Margin | 18.25% | 17.84% | 16.9% | 15.21% | 13.79% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.2B | -$2.1B | -$8.2B | -$768M | -$689M | |
| Operating Expenses | $35.1B | $37B | $38.2B | $39.8B | $41.6B | |
| Operating Income | $13.9B | $15.1B | $16.3B | $14.6B | $9.8B | |
| Net Interest Expenses | $2.9B | $2.5B | $2.3B | $2.7B | $3B | |
| EBT. Incl. Unusual Items | $9.8B | $10.5B | $5.8B | $11.2B | $6.1B | |
| Earnings of Discontinued Ops. | -$9M | -- | -- | -- | -- | |
| Income Tax Expense | $2.6B | $2.5B | $1.5B | $2.8B | $1.6B | |
| Net Income to Company | $7.2B | $8B | $4.3B | $8.4B | $4.6B | |
| Minority Interest in Earnings | -$13M | $12M | -$16M | -$24M | $28M | |
| Net Income to Common Excl Extra Items | $7.2B | $8B | $4.3B | $8.3B | $4.6B | |
| Basic EPS (Cont. Ops) | $5.48 | $6.07 | $3.29 | $6.49 | $3.67 | |
| Diluted EPS (Cont. Ops) | $5.46 | $6.02 | $3.26 | $6.47 | $3.66 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $17.1B | $17.5B | $12.3B | $18.2B | $13.7B | |
| EBIT | $12.7B | $13B | $8.1B | $13.8B | $9.1B | |
| Revenue (Reported) | $268.7B | $292.1B | $322.5B | $357.8B | $372.8B | |
| Operating Income (Reported) | $13.9B | $15.1B | $16.3B | $14.6B | $9.8B | |
| Operating Income (Adjusted) | $12.7B | $13B | $8.1B | $13.8B | $9.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $69.1B | $76.8B | $85.3B | $88.4B | $94.6B | |
| Revenue Growth (YoY) | 3.51% | 11.19% | 11% | 3.7% | 6.96% | |
| Cost of Revenues | $56.6B | $63.4B | $71.9B | $75.9B | $80.2B | |
| Gross Profit | $12.5B | $13.4B | $13.4B | $12.6B | $14.4B | |
| Gross Profit Margin | 18.09% | 17.43% | 15.68% | 14.2% | 15.22% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $50M | -$483M | -$327M | $25M | $28M | |
| Operating Expenses | $8.9B | $9.3B | $9.6B | $10.3B | $11B | |
| Operating Income | $3.6B | $4.1B | $3.8B | $2.3B | $3.4B | |
| Net Interest Expenses | $657M | $586M | $589M | $716M | $785M | |
| EBT. Incl. Unusual Items | $3B | $3B | $2.9B | $1.6B | $2.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $746M | $646M | $737M | $456M | $835M | |
| Net Income to Company | $2.2B | $2.4B | $2.1B | $1.1B | $1.8B | |
| Minority Interest in Earnings | -$1M | -$1M | -$6M | -$11M | -$3M | |
| Net Income to Common Excl Extra Items | $2.2B | $2.4B | $2.1B | $1.1B | $1.8B | |
| Basic EPS (Cont. Ops) | $1.69 | $1.79 | $1.66 | $0.88 | $1.41 | |
| Diluted EPS (Cont. Ops) | $1.68 | $1.77 | $1.65 | $0.88 | $1.41 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $4.8B | $4.6B | $4.5B | $3.4B | $4.6B | |
| EBIT | $3.6B | $3.6B | $3.5B | $2.3B | $3.4B | |
| Revenue (Reported) | $69.1B | $76.8B | $85.3B | $88.4B | $94.6B | |
| Operating Income (Reported) | $3.6B | $4.1B | $3.8B | $2.3B | $3.4B | |
| Operating Income (Adjusted) | $3.6B | $3.6B | $3.5B | $2.3B | $3.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $271B | $299.8B | $330.9B | $360.9B | $379B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $221.5B | $246.8B | $276.4B | $307.3B | $325.7B | |
| Gross Profit | $49.5B | $53B | $54.5B | $53.6B | $53.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.2B | -$2.6B | -$8B | -$416M | -$686M | |
| Operating Expenses | $35.5B | $37.4B | $38.5B | $40.5B | $42.3B | |
| Operating Income | $14B | $15.6B | $16B | $13.1B | $10.9B | |
| Net Interest Expenses | $2.8B | $2.4B | $2.3B | $2.8B | $3B | |
| EBT. Incl. Unusual Items | $10B | $10.6B | $5.7B | $9.9B | $7.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.5B | $2.4B | $1.6B | $2.5B | $1.9B | |
| Net Income to Company | $7.4B | $8.1B | $4.1B | $7.4B | $5.2B | |
| Minority Interest in Earnings | -$9M | $12M | -$21M | -$29M | $36M | |
| Net Income to Common Excl Extra Items | $7.4B | $8.1B | $4.1B | $7.3B | $5.3B | |
| Basic EPS (Cont. Ops) | $5.63 | $6.10 | $3.14 | $5.71 | $4.20 | |
| Diluted EPS (Cont. Ops) | $5.61 | $6.05 | $3.10 | $5.69 | $4.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $17.3B | $17.4B | $12.2B | $17.2B | $14.8B | |
| EBIT | $12.8B | $13B | $8B | $12.7B | $10.2B | |
| Revenue (Reported) | $271B | $299.8B | $330.9B | $360.9B | $379B | |
| Operating Income (Reported) | $14B | $15.6B | $16B | $13.1B | $10.9B | |
| Operating Income (Adjusted) | $12.8B | $13B | $8B | $12.7B | $10.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $69.1B | $76.8B | $85.3B | $88.4B | $94.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $56.6B | $63.4B | $71.9B | $75.9B | $80.2B | |
| Gross Profit | $12.5B | $13.4B | $13.4B | $12.6B | $14.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $50M | -$483M | -$327M | $25M | $28M | |
| Operating Expenses | $8.9B | $9.3B | $9.6B | $10.3B | $11B | |
| Operating Income | $3.6B | $4.1B | $3.8B | $2.3B | $3.4B | |
| Net Interest Expenses | $657M | $586M | $589M | $716M | $785M | |
| EBT. Incl. Unusual Items | $3B | $3B | $2.9B | $1.6B | $2.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $746M | $646M | $737M | $456M | $835M | |
| Net Income to Company | $2.2B | $2.4B | $2.1B | $1.1B | $1.8B | |
| Minority Interest in Earnings | -$1M | -$1M | -$6M | -$11M | -$3M | |
| Net Income to Common Excl Extra Items | $2.2B | $2.4B | $2.1B | $1.1B | $1.8B | |
| Basic EPS (Cont. Ops) | $1.69 | $1.79 | $1.66 | $0.88 | $1.41 | |
| Diluted EPS (Cont. Ops) | $1.68 | $1.77 | $1.65 | $0.88 | $1.41 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $4.8B | $4.6B | $4.5B | $3.4B | $4.6B | |
| EBIT | $3.6B | $3.6B | $3.5B | $2.3B | $3.4B | |
| Revenue (Reported) | $69.1B | $76.8B | $85.3B | $88.4B | $94.6B | |
| Operating Income (Reported) | $3.6B | $4.1B | $3.8B | $2.3B | $3.4B | |
| Operating Income (Adjusted) | $3.6B | $3.6B | $3.5B | $2.3B | $3.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.9B | $9.4B | $12.9B | $8.2B | $8.6B | |
| Short Term Investments | $3B | $3.1B | $2.8B | $3.3B | $2.4B | |
| Accounts Receivable, Net | $9.7B | $10.5B | $11.7B | $15.6B | $14.6B | |
| Inventory | $18.5B | $17.8B | $19.1B | $18B | $18.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.3B | $5.3B | $2.6B | $3.2B | $3.1B | |
| Total Current Assets | $56.4B | $60B | $65.6B | $67.9B | $68.6B | |
| Property Plant And Equipment | $33.3B | $32B | $30.7B | $30.4B | $28.9B | |
| Long-Term Investments | $20.8B | $23B | $21.1B | $23B | $28.9B | |
| Goodwill | $79.6B | $79.1B | $78.2B | $91.3B | $91.3B | |
| Other Intangibles | $31.1B | $29B | $24.8B | $29.2B | $27.3B | |
| Other Long-Term Assets | $4.6B | $4.7B | $4.6B | $4.7B | $4.8B | |
| Total Assets | $230.7B | $233B | $228.3B | $249.7B | $253.2B | |
| Accounts Payable | $11.1B | $12.5B | $14.8B | $14.9B | $15.9B | |
| Accrued Expenses | $14.2B | $17.7B | $18.7B | $23.5B | $20.8B | |
| Current Portion Of Long-Term Debt | $5.4B | $4.2B | $1.8B | $2.8B | $3.6B | |
| Current Portion Of Capital Lease Obligations | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Other Current Liabilities | $5.8B | $5.6B | $2.8B | $1.1B | $1.2B | |
| Total Current Liabilities | $62B | $67.8B | $69.4B | $79.2B | $84.6B | |
| Long-Term Debt | $59.2B | $52B | $50.5B | $58.6B | $60.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $161B | $157.6B | $156.5B | $173.1B | $177.5B | |
| Common Stock | $46.5B | $47.4B | $48.2B | $49B | $49.7B | |
| Other Common Equity Adj | $1.4B | $965M | -$1.3B | -$297M | -$120M | |
| Common Equity | $69.4B | $75.1B | $71.5B | $76.5B | $75.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $312M | $306M | $300M | $175M | $170M | |
| Total Equity | $69.7B | $75.4B | $71.8B | $76.6B | $75.7B | |
| Total Liabilities and Equity | $230.7B | $233B | $228.3B | $249.7B | $253.2B | |
| Cash and Short Terms | $10.9B | $12.5B | $15.7B | $11.5B | $11B | |
| Total Debt | $64.6B | $56.2B | $52.3B | $61.6B | $66.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.6B | $8.4B | $14.6B | $9.8B | $10.1B | |
| Short Term Investments | $3.2B | $2.9B | $3.1B | $3.3B | $2.6B | |
| Accounts Receivable, Net | $10.8B | $12.2B | $12.9B | $16B | $16.7B | |
| Inventory | $17.6B | $18.2B | $18.3B | $16.3B | $17.4B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.5B | $5.5B | $3.8B | $5.8B | $3.5B | |
| Total Current Assets | $55.7B | $61.5B | $68.7B | $67.5B | $73.2B | |
| Property Plant And Equipment | $33.2B | $31.6B | $30.5B | $30.1B | $28.6B | |
| Long-Term Investments | $21B | $22.6B | $21.6B | $24.1B | $28.9B | |
| Goodwill | $79.6B | $79.1B | $84.1B | $91.3B | $91.2B | |
| Other Intangibles | $30.6B | $28.5B | $26.4B | $28.8B | $26.6B | |
| Other Long-Term Assets | $4.8B | $4.9B | $4.8B | $4.8B | $5.2B | |
| Total Assets | $229.6B | $232.9B | $239.3B | $249.7B | $255.6B | |
| Accounts Payable | $10.8B | $12.7B | $12.5B | $13.7B | $16.5B | |
| Accrued Expenses | $14.3B | $16.6B | $21.5B | $22.4B | $22.4B | |
| Current Portion Of Long-Term Debt | $2.4B | $4.2B | $1.8B | $6.5B | $4.4B | |
| Current Portion Of Capital Lease Obligations | $1.8B | $1.8B | $1.7B | $1.9B | $1.9B | |
| Other Current Liabilities | $6B | $5.5B | $6.6B | $2.2B | $1.6B | |
| Total Current Liabilities | $60.1B | $69.8B | $75.1B | $83.3B | $89B | |
| Long-Term Debt | $59.3B | $52.1B | $56.5B | $57.7B | $59B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $158.4B | $158.7B | $167.8B | $175.6B | $178.5B | |
| Common Stock | $46.7B | $47.7B | $48.3B | $49.2B | $49.8B | |
| Other Common Equity Adj | $1B | -$190M | -$875M | -$341M | $59M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $314M | $310M | $198M | $182M | $181M | |
| Total Equity | $71.2B | $74.1B | $71.6B | $74.2B | $77.1B | |
| Total Liabilities and Equity | $229.6B | $232.9B | $239.3B | $249.7B | $255.6B | |
| Cash and Short Terms | $8.8B | $11.3B | $17.7B | $13.1B | $12.7B | |
| Total Debt | $61.9B | $56.3B | $58.2B | $64.1B | $64.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2B | $8B | $4.3B | $8.4B | $4.6B | |
| Depreciation & Amoritzation | $4.4B | $4.5B | $4.2B | $4.4B | $4.6B | |
| Stock-Based Compensation | $400M | $484M | $447M | $588M | $540M | |
| Change in Accounts Receivable | -$1.5B | -$2.7B | -$3B | -$6.3B | -$1.3B | |
| Change in Inventories | -$973M | $735M | -$1.4B | $1.2B | -$102M | |
| Cash From Operations | $15.9B | $18.3B | $16.2B | $13.4B | $9.1B | |
| Capital Expenditures | $2.4B | $2.5B | $2.7B | $3B | $2.8B | |
| Cash Acquisitions | -$26M | -$146M | -$1.4B | -$16.6B | -$95M | |
| Cash From Investing | -$5.5B | -$5.3B | -$5B | -$20.9B | -$7.6B | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.6B | -$2.9B | -$3.1B | -$3.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $10B | $987M | -- | $16.1B | $9.8B | |
| Long-Term Debt Repaid | -$15.6B | -$10.3B | -$4.2B | -$8.2B | -$4.8B | |
| Repurchase of Common Stock | -- | -- | -$3.5B | -$2B | -$3B | |
| Other Financing Activities | $337M | -$13M | -$449M | -$382M | -$159M | |
| Cash From Financing | -$7.7B | -$11.4B | -$10.5B | $2.7B | -$1.1B | |
| Beginning Cash (CF) | $8.4B | $11B | $12.7B | $13.3B | $8.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6B | $1.6B | $614M | -$4.8B | $359M | |
| Ending Cash (CF) | $11B | $12.7B | $13.3B | $8.5B | $8.9B | |
| Levered Free Cash Flow | $13.4B | $15.7B | $13.5B | $10.4B | $6.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2B | $2.4B | $2.1B | $1.1B | $1.8B | |
| Depreciation & Amoritzation | $1.1B | $1B | $1B | $1.1B | $1.2B | |
| Stock-Based Compensation | $87M | $89M | $103M | $137M | $126M | |
| Change in Accounts Receivable | -$2.1B | -$2B | -$751M | $3B | -$3.1B | |
| Change in Inventories | $879M | -$400M | $828M | $1.7B | $722M | |
| Cash From Operations | $2.9B | $3.6B | $7.4B | $4.9B | $4.6B | |
| Capital Expenditures | $829M | $1.1B | $984M | $705M | $743M | |
| Cash Acquisitions | -$84M | -$7M | -$7.1B | -$25M | -$20M | |
| Cash From Investing | -$1.9B | -$2B | -$8.5B | -$2.1B | -$762M | |
| Dividends Paid (Ex Special Dividend) | -$656M | -$722M | -$779M | -$840M | -$840M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $252M | -- | $6B | -- | -- | |
| Long-Term Debt Repaid | -$3B | -$14M | -$362M | -$18M | -$743M | |
| Repurchase of Common Stock | -- | -$2B | -$2B | -$3B | -- | |
| Other Financing Activities | $56M | -$211M | -$162M | -$64M | -$34M | |
| Cash From Financing | -$3.2B | -$2.7B | $2.7B | -$1.2B | -$2.3B | |
| Beginning Cash (CF) | $11B | $12.7B | $13.3B | $8.5B | $8.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.2B | -$1.1B | $1.7B | $1.6B | $1.5B | |
| Ending Cash (CF) | $8.9B | $11.6B | $15B | $10.1B | $10.3B | |
| Levered Free Cash Flow | $2.1B | $2.5B | $6.5B | $4.2B | $3.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.4B | $8.1B | $4.1B | $7.4B | $5.2B | |
| Depreciation & Amoritzation | $4.5B | $4.4B | $4.2B | $4.5B | $4.6B | |
| Stock-Based Compensation | $391M | $486M | $461M | $622M | $529M | |
| Change in Accounts Receivable | -$888M | -$2.6B | -$1.8B | -$2.5B | -$7.4B | |
| Change in Inventories | -$635M | -$544M | -$207M | $2.1B | -$1B | |
| Cash From Operations | $15.5B | $18.9B | $20.1B | $10.9B | $8.8B | |
| Capital Expenditures | $2.5B | $2.7B | $2.7B | $2.8B | $2.8B | |
| Cash Acquisitions | $503M | -$69M | -$8.5B | -$9.5B | -$90M | |
| Cash From Investing | -$5.8B | -$5.4B | -$11.6B | -$14.5B | -$6.3B | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.7B | -$3B | -$3.2B | -$3.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.3B | $735M | $6B | $12.7B | -- | |
| Long-Term Debt Repaid | -$17.7B | -$7.2B | -$4.6B | -$7.8B | -$5.5B | |
| Repurchase of Common Stock | -- | -$2B | -$3.5B | -$3B | $4M | |
| Other Financing Activities | $413M | -$280M | -$400M | -$284M | -$129M | |
| Cash From Financing | -$13.6B | -$10.8B | -$5.1B | -$1.3B | -$2.2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.9B | $2.7B | $3.3B | -$4.8B | $239M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $12.9B | $16.2B | $17.4B | $8.1B | $5.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2B | $2.4B | $2.1B | $1.1B | $1.8B | |
| Depreciation & Amoritzation | $1.1B | $1B | $1B | $1.1B | $1.2B | |
| Stock-Based Compensation | $87M | $89M | $103M | $137M | $126M | |
| Change in Accounts Receivable | -$2.1B | -$2B | -$751M | $3B | -$3.1B | |
| Change in Inventories | $879M | -$400M | $828M | $1.7B | $722M | |
| Cash From Operations | $2.9B | $3.6B | $7.4B | $4.9B | $4.6B | |
| Capital Expenditures | $829M | $1.1B | $984M | $705M | $743M | |
| Cash Acquisitions | -$84M | -$7M | -$7.1B | -$25M | -$20M | |
| Cash From Investing | -$1.9B | -$2B | -$8.5B | -$2.1B | -$762M | |
| Dividends Paid (Ex Special Dividend) | -$656M | -$722M | -$779M | -$840M | -$840M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $252M | -- | $6B | -- | -- | |
| Long-Term Debt Repaid | -$3B | -$14M | -$362M | -$18M | -$743M | |
| Repurchase of Common Stock | -- | -$2B | -$2B | -$3B | -- | |
| Other Financing Activities | $56M | -$211M | -$162M | -$64M | -$34M | |
| Cash From Financing | -$3.2B | -$2.7B | $2.7B | -$1.2B | -$2.3B | |
| Beginning Cash (CF) | $11B | $12.7B | $13.3B | $8.5B | $8.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.2B | -$1.1B | $1.7B | $1.6B | $1.5B | |
| Ending Cash (CF) | $8.9B | $11.6B | $15B | $10.1B | $10.3B | |
| Levered Free Cash Flow | $2.1B | $2.5B | $6.5B | $4.2B | $3.8B | |
Get CVS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CVS
Sector
P/E ratio
15.23x
23.88x
PEG ratio
0.07x
0.00x
P/B ratio
1.05x
1.80x
Price / LTM sales
0.21x
1.65x
Growth Metrics
CVS
Sector
Revenue growth
6.96%
4.06%
Earnings growth
60.23%
7.46%
Revenue (5-year growth)
7.74%
8.01%
Earnings forecast
$1.47
-$0.20
Profitability
CVS
Sector
Profitability FY 2024
$51.4B
$47.5M
Return on invested capital
3.75%
-16.26%
Return on assets
2.09%
-13.27%
Return on equity
7%
-18.61%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
31
Balance Sheet
CVS
Sector
Total cash
$12.7B
$35.5M
Short term investments
$2.4B
$29.7M
Total assets
$253.2B
$106.9M
Long term debt
$64.7B
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
